Premium
Biologic treatments for rheumatoid arthritis
Author(s) -
Kotecha Jalpa B,
Kiely Patrick DW
Publication year - 2019
Publication title -
trends in urology and men's health
Language(s) - English
Resource type - Journals
eISSN - 2044-3749
pISSN - 2044-3730
DOI - 10.1002/tre.711
Subject(s) - rheumatoid arthritis , antirheumatic drugs , medicine , antirheumatic agents , biologic agents , intensive care medicine , physical therapy
Biologic disease‐modifying antirheumatic drugs (bDMARDs) have made a significant difference to the lives of people with rheumatoid arthritis (RA), in particular those who do not respond to conventional drugs. In this article the authors review the place in therapy of bDMARDs for RA and consider a range of factors that could contribute to further improvements to patient otucomes.